178 related articles for article (PubMed ID: 3502060)
1. Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates.
Wiesel FA; Wik G; Sjögren I; Blomqvist G; Greitz T; Stone-Elander S
Acta Psychiatr Scand; 1987 Dec; 76(6):628-41. PubMed ID: 3502060
[TBL] [Abstract][Full Text] [Related]
2. Altered relationships between metabolic rates of glucose in brain regions of schizophrenic patients.
Wiesel FA; Wik G; Sjögren I; Blomqvist G; Greitz T
Acta Psychiatr Scand; 1987 Dec; 76(6):642-7. PubMed ID: 3442255
[TBL] [Abstract][Full Text] [Related]
3. Cortical sulcal enlargement in catatonic schizophrenia: a planimetric CT study.
Northoff G; Waters H; Mooren I; Schlüter U; Diekmann S; Falkai P; Bogerts B
Psychiatry Res; 1999 Jul; 91(1):45-54. PubMed ID: 10496691
[TBL] [Abstract][Full Text] [Related]
4. Effects of sulpiride and chlorpromazine on regional cerebral glucose metabolism in schizophrenic patients as determined by positron emission tomography.
Wik G; Wiesel FA; Sjögren I; Blomqvist G; Greitz T; Stone-Elander S
Psychopharmacology (Berl); 1989; 97(3):309-18. PubMed ID: 2497479
[TBL] [Abstract][Full Text] [Related]
5. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
[TBL] [Abstract][Full Text] [Related]
6. Regional brain glucose metabolism: correlations to biochemical measures and anxiety in patients with schizophrenia.
Wik G; Wiesel FA
Psychiatry Res; 1991 Oct; 40(2):101-14. PubMed ID: 1722339
[TBL] [Abstract][Full Text] [Related]
7. Quantitative computed tomographic study in schizophrenia: cerebral density and ventricle measures.
Rossi A; Stratta P; D'Albenzio L; Di Michele V; Serio A; Giordano L; Petruzzi C; Casacchia M
Psychol Med; 1989 May; 19(2):337-42. PubMed ID: 2762438
[TBL] [Abstract][Full Text] [Related]
8. Patterns of cortical activity in schizophrenia.
Schroeder J; Buchsbaum MS; Siegel BV; Geider FJ; Haier RJ; Lohr J; Wu J; Potkin SG
Psychol Med; 1994 Nov; 24(4):947-55. PubMed ID: 7892362
[TBL] [Abstract][Full Text] [Related]
9. PET studies of glucose metabolism in patients with schizophrenia.
Widen L; Blomqvist G; Greitz T; Litton JE; Bergström M; Ehrin E; Ericson K; Eriksson L; Ingvar DH; Johansson L; Nilsson JL; Stone-Elander S; Sedvall G; Wiesel F; Wiik G
AJNR Am J Neuroradiol; 1983; 4(3):550-2. PubMed ID: 6136180
[TBL] [Abstract][Full Text] [Related]
10. Abnormal glucose metabolism in the anterior cingulate cortex in patients with schizophrenia.
Fujimoto T; Takeuch K; Matsumoto T; Kamimura K; Hamada R; Nakamura K; Kato N
Psychiatry Res; 2007 Jan; 154(1):49-58. PubMed ID: 17188463
[TBL] [Abstract][Full Text] [Related]
11. PET determination of regional cerebral glucose metabolism in alcohol-dependent men and healthy controls using 11C-glucose.
Wik G; Borg S; Sjögren I; Wiesel FA; Blomqvist G; Borg J; Greitz T; Nybäck H; Sedvall G; Stone-Elander S
Acta Psychiatr Scand; 1988 Aug; 78(2):234-41. PubMed ID: 2851920
[TBL] [Abstract][Full Text] [Related]
12. A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography.
Potkin SG; Alva G; Fleming K; Anand R; Keator D; Carreon D; Doo M; Jin Y; Wu JC; Fallon JH
Am J Psychiatry; 2002 Feb; 159(2):227-37. PubMed ID: 11823264
[TBL] [Abstract][Full Text] [Related]
13. Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia.
Cleghorn JM; Garnett ES; Nahmias C; Firnau G; Brown GM; Kaplan R; Szechtman H; Szechtman B
Psychiatry Res; 1989 May; 28(2):119-33. PubMed ID: 2787515
[TBL] [Abstract][Full Text] [Related]
14. Correlational patterns of cerebral glucose metabolism in never-medicated schizophrenics.
Katz M; Buchsbaum MS; Siegel BV; Wu J; Haier RJ; Bunney WE
Neuropsychobiology; 1996; 33(1):1-11. PubMed ID: 8821368
[TBL] [Abstract][Full Text] [Related]
15. Reduced regional brain glucose metabolism assessed by positron emission tomography in electrodermal nonresponder schizophrenics: a pilot study.
Hazlett EA; Dawson ME; Buchsbaum MS; Nuechterlein KH
J Abnorm Psychol; 1993 Feb; 102(1):39-46. PubMed ID: 8436698
[TBL] [Abstract][Full Text] [Related]
16. Gross brain morphology in schizophrenia: a regional analysis of traditional diagnostic subtypes.
Raz S
J Consult Clin Psychol; 1994 Jun; 62(3):640-4. PubMed ID: 8063992
[TBL] [Abstract][Full Text] [Related]
17. Functional and anatomical brain imaging: impact on schizophrenia research.
Buchsbaum MS; Haier RJ
Schizophr Bull; 1987; 13(1):115-32. PubMed ID: 3496658
[TBL] [Abstract][Full Text] [Related]
18. The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography.
Eidelberg D; Dhawan V; Moeller JR; Sidtis JJ; Ginos JZ; Strother SC; Cederbaum J; Greene P; Fahn S; Powers JM
J Neurol Neurosurg Psychiatry; 1991 Oct; 54(10):856-62. PubMed ID: 1744638
[TBL] [Abstract][Full Text] [Related]
19. Kraepelinian and non-Kraepelinian schizophrenia subgroup differences in cerebral metabolic rate.
Buchsbaum MS; Shihabuddin L; Hazlett EA; Schröder J; Haznedar MM; Powchik P; Spiegel-Cohen J; Wei T; Singer MB; Davis KL
Schizophr Res; 2002 May; 55(1-2):25-40. PubMed ID: 11955961
[TBL] [Abstract][Full Text] [Related]
20. Regional metabolism in microsmic patients with schizophrenia.
Clark C; Kopala L; Hurwitz T; Li D
Can J Psychiatry; 1991 Nov; 36(9):645-50. PubMed ID: 1685350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
